Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in cows following single dose intravenous administration.

[1]  S. Räisänen,et al.  Pharmacokinetics of enrofloxacin in newborn and one-week-old calves. , 1997, Journal of veterinary pharmacology and therapeutics.

[2]  P. Nielsen,et al.  Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. , 1997, Pharmacology & toxicology.

[3]  M. Salonen,et al.  Disposition of enrofloxacin (Baytril) into the udder after intravenous and intra-arterial injections into dairy cows. , 1996, Zentralblatt fur Veterinarmedizin. Reihe A.

[4]  K. Küng,et al.  Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. , 1993, Journal of veterinary pharmacology and therapeutics.

[5]  J J Schentag,et al.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients , 1993, Antimicrobial Agents and Chemotherapy.

[6]  D. Aucoin,et al.  Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. , 1991, Journal of veterinary pharmacology and therapeutics.

[7]  J. Blaser,et al.  Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance , 1987, Antimicrobial Agents and Chemotherapy.

[8]  J. Prescott,et al.  In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. , 1990, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.